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Background: The rate of vertical HIV transmission has decreased in Brazil, but regional inequalities suggest
problems in implementing control measures during pregnancy and delivery. The aims of this study were to
ascertain the coverage of HIV testing during prenatal care and estimate the prevalence of HIV infection during
pregnancy in Brazil.
Methods: This was a national hospital-based study of 23,894 women that was conducted in 2011–2012. The data
came from interviews with mothers during postpartum hospitalization, from hospital medical files and from prenatal
cards. All the pregnant women with reactive serological results for HIV infection marked on their cards or with
diagnoses of HIV infection during the hospital stay for delivery were considered cases of HIV infection. Univariate
and multivariable logistic regression were performed to investigate factors associated with the prevalence of HIV
infection and with performing at least one HIV test during pregnancy.
Results: Among participating women, the coverage of testing for HIV infection was 81.7% among those who
presented with prenatal card and the prevalence of HIV infection among pregnant women was 0.4% (95% CI:
0.32-0.51%). In the adjusted analysis, there was higher coverage of testing among women living in the South
and Southeast regions; of women aged 35 years and over; with greater schooling levels; who self-reported as
white; with prenatal care provided in private services; with an early start to prenatal care; and with an adequate
number of consultations, defined as a minimum of six for a term pregnancy. In the adjusted analyses there was
a greater odds ratio of HIV infection among women living in the South region, aged 35 years and over, with
schooling of less than 8 years, who self-reported race as black, without a partner, with syphilis coinfection and
who were attended by public services.
Conclusions: The prevalence of HIV infection among pregnant women in Brazil remains below 1% and the
coverage of testing for HIV infection is over 80%. However, the regional and social inequalities in access to
healthcare services and the missed opportunities for diagnoses of HIV infection indicate the importance of
strengthening HIV infection control programs during pregnancy.
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Vertical transmission of HIV from mother to fetus dur-
ing pregnancy, delivery and the postpartum period can
be avoided in almost all cases through existing interven-
tions, such as use of antiretroviral therapy, elective
cesarean section and avoidance of breastfeeding [1].
Nonetheless, it has been estimated in 2009 that, world-
wide, 370,000 children become infected with HIV every
year [2].
Brazil has a concentrated AIDS epidemic with a stable
prevalence estimated to be less than 1% [3]. Increased
heterosexual transmission has resulted in an increased
number of cases among women, while vertical HIV
transmission from mother to child during pregnancy
and delivery accounts for almost all of the cases reported
among children [3]. Based on the last Sentinel Parturient
Studies, conducted in 2006 [4] and 2010 [3], it was esti-
mated that approximately 0.4% of pregnant women in
Brazil have HIV infection. Given the number of cases of
HIV infection reported among pregnant women in 2012,
it was inferred that HIV surveillance among pregnant
women only reached 58.3% of expected cases, [3] thus
indicating that there were some difficulties in diagnosing
and/or reporting cases.
In Brazil, several government initiatives have made
tests, medications, infant formula feeding and care rou-
tines available for managing HIV during pregnancy, de-
livery and the postpartum period since the end of the
1990s [5]. Studies with national coverage in Brazil have
shown that reductions in vertical transmission started to
occur from 1997 onwards [6-9]. The estimated vertical
transmission rate was 6.8% in 2004, with a range from
13.4% in the North region to 4.3% in the Midwest region
[10]. Local studies conducted in the Southeast region
[11-14] have reported vertical transmission rates closer to
3%, while rates of less than or equal to 2% have been found
in the Midwest and South regions [15-17]. In contrast, in
the North and Northeast regions and in the state of São
Paulo, local studies have found vertical transmission rates
of 9.9% [18], 9.2% [19] and 6.0% [20], respectively.
Thus, despite advances, flaws in the Brazilian control
program for HIV during pregnancy have prevented reach-
ing vertical transmission rates of less than 2%, like the rates
found in some developed countries such as the United
Kingdom [21]. The Pan-American Health Organization
(PAHO) has a target of eliminating vertical transmission of
HIV from the Latin American and Caribbean region by
2015, which translates into reaching a vertical transmission
rate of less than or equal to 2% and an incidence of cases
of vertical transmission of HIV of less than or equal to 0.3
per 1,000 live births [22].
Identification of HIV-infected pregnant women is the
first stage towards adopting the protocols available for
both prevention of vertical transmission and treatmentof women. Local studies [13,15,18,19,23,24] have indi-
cated that the coverage of HIV testing has increased in
all Brazilian regions. However, these results were from
studies with municipal or state coverage while no studies
with national coverage that could adequately provide es-
timates for the country have been conducted recently.
The aims of the present study were to ascertain the
coverage of HIV testing during prenatal care, to evaluate
the factors associated with performing at least one HIV
testing during pregnancy and to estimate the prevalence
of HIV infection among pregnant women in Brazil
through a survey with national coverage that was con-
ducted among puerperal women who underwent deliv-
ery in hospitals in 2011–2012.
Methods
The study “Birth in Brazil: national survey into labour
and birth” was a hospital-based study conducted be-
tween February 2011 and October 2012. Additional in-
formation on the methodology of the study “Birth in
Brazil” can be obtained from Leal et al. [25].
The sample was selected in three stages. In the first stage,
hospitals with more than 500 deliveries per year were strati-
fied according to the five macroregions of the country
(North, Northeast, South, Southeast and Midwest), accord-
ing to location (state capital or elsewhere in the state) and
type of hospital service (public, mixed or private), and 266
hospitals were selected with a probability of selection pro-
portional to the number of deliveries in each of the strata
in 2007. The minimum size of the sample in each of the
strata was 450 puerperal women. In the second stage, the
number of days needed to interview 90 puerperal women
in each hospital (minimum of 7) was selected by using an
inverse sampling method. In the third stage, the women eli-
gible on each day of the fieldwork were selected [26]. Sam-
ple losses due to refusal to participate or hospital discharge
were replaced by selecting new puerperal women at the
same hospital. In total, interviews were conducted with
23,894 women.
All puerperal women with live births in a hospital in
which the fetus had any gestational age or weight, or a
stillbirth in which the fetus had a gestational age of more
than 22 weeks recorded in the medical file or weight
greater than 500 grams, were considered eligible for the
study. Miscarriages were excluded as the aim of the
study was to evaluate the conditions of prenatal, birth
and delivery care and the results from the care provided.
Interviews with the puerperal women were conducted
during their hospital stay, at least 6 hours after delivery.
Data from the medical files of the puerperal woman and
newborn were obtained at the time of hospital discharge.
In case of prolonged hospitalization, data from medical
files were obtained at the 42nd day of hospitalization in
the case of the puerperal women or the 28th day of life
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traction of data from the medical files, electronic forms
that had been developed specifically for this study were
used. When available, prenatal cards, which are official
forms provided by health services to all pregnant women
during prenatal care where tests, procedures, and pre-
scription drugs are recorded, were photographed in
digital media with subsequent extraction and input of
data into an online platform. This was done by a team of
students and healthcare professionals who had been
trained and were supervised by the central coordinating
team of the study.
To evaluate the prenatal care, the protocols of the
Ministry of Health were used. These recommend that pre-
natal care should begin by the 12th gestational week [27],
with a minimum of six consultations during follow-up.
Furthermore, there should be two HIV serological tests
over the course of the pregnancy: the first serological test
should be requested at the time of the first prenatal visit
and the second serological test should be requested at the
start of the third trimester of the pregnancy [28].
In the present study, the following prenatal care indi-
cators were estimated: proportion of puerperal women
who reported having at least one prenatal consultation;
proportion of puerperal women who reported having re-
ceived a prenatal card; proportion of puerperal women
who had their prenatal card at the time of hospital ad-
mission for delivery; and proportion of puerperal women
with records of the first and second HIV tests on their
card. It was assumed that the tests had been carried out
when there was a record of any serological result relat-
ing to HIV. Other data on prenatal care that were ana-
lyzed in the “Birth in Brazil” study are available in
Viellas et al. [29].
For the diagnosis of HIV infection during pregnancy,
one of the following were considered: 1) reactive results
recorded on the prenatal card (two rapid tests or Elisa +
immunofluorescence or Elisa +Western Blota); and/or 2)
records in the hospital medical files of a) diagnosis of
HIV infection or b) indication of cesarean due to HIV
infection or c) use of zidovudine during delivery labor
and/or delivery or d) use of zidovudine syrup for the
newborn or e) suspension of breastfeeding due to mater-
nal HIV infection or f) record of the diagnosis of “child
exposed to HIV”.
The prenatal care indicators were analyzed according
to the following maternal characteristics: “region of resi-
dence” (North, Northeast, Southeast, South or Midwest);
“age” (12 to 19 years, 20 to 34 years or 35 years and
over); “schooling level” (up to 7 years, 8 to 10 years or
11 or more years of school attendance); “self-reported
skin color” (white, black, mixed, East Asian or indigen-
ous); “conjugal situation” (with or without a partner);
“type of prenatal care service” where most of theconsultations were attended (public or private); and
“type of delivery care service” (public, mixed or private;
mixed services were taken to be those that attended to
women with either public or private funding for delivery
care). The chi-square statistical test was used to ascer-
tain differences between proportions.
To evaluate the factors associated with performing at
least one HIV testing during pregnancy, univariate and
multivariable logistic regressions were performed. In
addition to the maternal characteristics, the following
variables relating to prenatal care were included: the
time when prenatal care began measured in gestational
weeks (up to week 12, between weeks 13 and 28, or
week 29 and beyond); and the adequacy of the number
of consultations up to the time of delivery, considering a
minimum of six consultations for a term pregnancy, ad-
justed for the gestational age at birth (sufficient or insuf-
ficient), according to the criteria defined by the Ministry
of Health.
To evaluate the factors associated with HIV infection
among pregnant women, univariate and multivariable re-
gressions were performed. In addition to the maternal
characteristics described above, “diagnosis of syphilis in-
fection during pregnancy” (yes or no) was also included,
as some authors point to high rates of coinfection
[30,31]. The women were considered to present with
syphilis infection if they presented with one of the fol-
lowing criteria: record of a reactive serological test on
the prenatal card or hospital medical file; record of syph-
ilis diagnosis on the prenatal card or hospital medical
file; or case of congenital syphilis as an outcome from
the current pregnancy.
A univariate analysis estimated the unadjusted odds ra-
tio (OR) and 95% confidence interval (95% CI). Variables
with a significance level estimated as lower than 0.20 were
included in an initial multivariable model and those with a
significance level of <0.05 were retained in the final multi-
variable model. The results from the multivariable model
were expressed as adjusted odds ratios with their corre-
sponding 95% confidence intervals (95% CI).
In all the statistical analyses, the complex sampling de-
sign was taken into consideration. The data weighting
was calculated according to the inverse of the probability
of inclusion of each puerperal woman in the sample. To
ensure that the distribution of the puerperal women
interviewed was similar to that observed among the
births in the population sampled in 2011, a calibration
procedure was used in each selection stratum [26]. For
the univariate and multivariable logistic regression, the
women who self-reported as East Asian or indigenous
were excluded because they accounted for a very small
proportion of the sample. Analyses were performed
using IBM SPSS software version 19.0 (IBM Corp.,
Armonk, USA).
Table 1 Demographic and social characteristics and
prenatal and delivery care service use, Brazil, 2011-2012








12 to 19 years 4.570 19.1
20 to 34 years 16.807 70.4
35 and over 2.509 10.5
Schooling level (years)
11 or more 11.371 47,8
8 to 10 6.085 25.6





East Asian 257 1.1
Indigenous 99 0.4
Conjugal situation
With partner 19.439 81.4
Without partner 4.432 18.5
Type of prenatal care service
No prenatal consultations 319 1.3
Public clinic 17.575 73.6
Private clinic 5.971 25.0
Start of prenatal care
> week 28 857 3.7
Weeks 13 to 28 8.382 35.8
Up to week 12 14.182 60.6
Adequacy of number of consultations1
No 6.782 28.4
Yes 17.112 71.6





Totals for these variables vary because of missing values. For start of prenatal
care and adequacy of number of consultations, total available for women who
had prenatal care. 1Considering a minimum of six consultations for a term
pregnancy, adjusted for gestational age at delivery.
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Committee of ENSP/Fiocruz, under report no. 92/2010.
Every care was taken towards ensuring privacy and confi-
dentiality of the information. Before each interview was
conducted, the interviewee’s consent was obtained, after
reading the free and informed consent statement.
Results
Among the puerperal women selected to participate in
the study, 5.7% were not interviewed either because they
refused to participate or because they were discharged
early. The majority of the puerperal women were living
in the Southeast region (42.5%) and Northeast region
(28.9%), which are the most populous regions of the
country. The Midwest region had the lowest proportion
(6.5%). The mean age of the women was 25.7 years, with
a median of 25 years, and 19.1% were up to19 years of
age. Half of the interviewees had attended school for up
to 10 years and 8.9% had a college degree. The majority
self-reported their skin color as mixed (56.1%), while
East Asian and indigenous skin colors accounted for
1.1% and 0.4% of the sample total, respectively. More
than 80% of the women said they had a partner. Nearly
99.0% of the puerperal women had had at least one pre-
natal consultation, 60.6% began their prenatal care early,
i.e., up to the 12th gestational week, and 71.6% had had
sufficient consultations. More than 70% of the pregnant
women had been attended in public clinics for their pre-
natal care, and only 14.5% had had their delivery in a
private healthcare unit (Table 1).
Table 2 presents the prenatal care indicators: 96% of
the puerperal women reported that they had received a
prenatal card during their prenatal period and 71.6%
presented with the card at the time of hospital admis-
sion for delivery. Of the analyzed cards, 81.7% had the
results from the first HIV test recorded and 28.4% had
the results from the second HIV test recorded.
Fewer records of results from the first HIV test were
observed in the North and Northeast regions; among
women with a lower schooling level; among women who
self-reported as black, mixed and East Asian; among
those under 20 years of age; among those without a
companion; and among those with prenatal and delivery
care provided in public clinics. A similar pattern was ob-
served for the results from the second HIV test, except
in relation to the location where prenatal consultations
took place: there was no difference between public and
private clinics (Table 2).
In the multivariable analysis, having at least one HIV
test during the pregnancy was associated with the region
of residence, such that there was a greater odds of testing
in the South region; with maternal age greater than or
equal to 35 years; with prenatal care provided in private
clinics; with an early start to prenatal care, particularly
Table 2 Prenatal care and anti-HIV tests performed according to maternal and service characteristics, Brazil, 2011-2012









test (n = 16.899)
Results from two
anti-HIV serological
tests (n = 16.899)
% p1 % p1 % p1 % p1 % p1
Region of residence
Southeast 10.155 98.8 0.006 96.3 0.130 77.5 <0.001 88.2 <0.001 33.3 <0.001
North 2.296 97.5 97.9 64.2 69.9 18.4
Northeast 6.904 98.5 94.9 67.9 68.4 15.1
South 2.984 99.5 97.1 79.7 92.8 41.7
Midwest 1.555 98.7 94.2 45.1 83.2 36.8
Maternal age
12 to 19 years 4.570 98.5 0.497 98.7 <0.001 74.7 <0.001 75.2 <0.001 26.0 0.020
20 to 34 years 16.807 98.7 95.8 71.7 83.0 28.7
35 and over 2.509 98.7 92.4 65.9 85.8 31.0
Schooling level, (years)
11 or more 11.362 99.6 <0.001 93.4 <0.001 67.6 <0.001 88.2 <0.001 32.5 <0.001
8 to 10 6.081 98.8 98.0 74.5 80.8 28.5
0 to 7 6.317 96.9 98.9 76.2 72.3 21.5
Skin color
White 8.079 99.2 0.001 94.2 <0.001 70.3 0.422 88.6 <0.001 34.6 <0.001
Mixed 13.403 98.5 96.8 72.1 78.3 25.3
Black 2.051 98.1 98.4 73.4 77.1 24.5
East Asian 257 98.3 93.5 73.9 77.7 27.0
Indigenous 99 95.0 98.2 80.1 91.7 34.4
Conjugal situation
With partner 19.439 99.1 95.7 71.2 82.4 28.9
Without partner 4.432 96.9 <0.001 97.4 0.002 73.4 0.107 78.7 0.001 26.1 0.023
Type of prenatal service
Public clinic 17.575 — — 99.3 <0.001 76.3 <0.001 79.3 <0.001 27.6 0.116
Private clinic 5.971 — — 86.3 58.0 91.2 31.4
Type of delivery service
Public 9.836 97.8 <0.001 99.0 <0.001 73.9 <0.001 76.3 <0.001 24.8 0.036
Mixed 10.596 99.1 97.8 77.0 84.3 30.8
Private 3.462 99.9 82.2 49.2 91.6 32.0
Total 23.894 98.7 96.0 71.6 81.7 28.4
1Chi-square statistical test.
Totals for these variables vary because of missing values. For type of prenatal service, total available for women who had prenatal care.
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number of prenatal consultations. A lower odds of testing
was observed for women who lived in the North and
Northeast regions, who self-reported black or mixed and
who had fewer years of schooling. No differences relating
to conjugal situation were observed (Table 3).
Table 4 shows the prevalence of HIV infection among
pregnant women, which was estimated to be 0.40% (95%
CI: 0.32-0.51%). In the unadjusted analysis, a greaterprevalence of infection was observed in the South than in
the Southeast region. The prevalence increased with in-
creasing maternal age and with decreasing schooling level.
There was greater prevalence among women who self-
reported as black, those without a companion, those with
a diagnosis of syphilis during pregnancy and those whose
delivery care was provided in public or mixed clinics.
The results from the adjusted analysis (Table 4)
showed that women living in the South region continued
Table 3 Univariate and multivariable logistic regression on factors associated with performing one anti-HIV test, Brazil,
2011-2012
Maternal and prenatal care characteristics n1 One anti-HIV test performed
during prenatal care (%)
Univariate analysis Multivariable analysis2
OR3 95% CI4 p OR3 95% CI4 p
Region of residence
Southeast 7.783 88.2 1 1
North 1.439 69.9 0.31 0.19-0.50 <0.001 0.47 0.30-0.76 <0.001
Northeast 4.616 68.4 0.29 0.21-0.40 0.38 0.28-0.52
South 2.365 92.9 1.75 1.21-2.55 1.77 1.20-2.59
Midwest 694 83.2 0.67 0.42-1.06 0.79 0.53-1.18
Maternal age
12 to 19 years 3.364 75.2 1 <0.001 1
20 to 34 years 11.894 83.0 1.61 1.40-1.85 1.12 0.95-1.31 0.033
35 and over 1.633 85.8 2.00 1.64-2.46 1.33 1.07-1.64
Schooling level (years)
11 or more 7.658 88.2 1 1
8 to 10 4.481 80.7 0.56 0.49-0.65 <0.001 0,78 0.68-0.90 <0.001
0 to 7 4.669 72.3 0.35 0.30-0.41 0,64 0.54-0.76
Skin color5
White 5.634 88.6 1 1
Mixed 9.520 78.3 0.43 0.34- 0.55 <0.001 0.77 0.67-0.90 0.001
Black 1.478 77.1 0.46 0.39- 0.53 0.73 0.57-0.94
Conjugal situation
With partner 13.724 82.4 1 1
Without partner 3.155 78.7 0.79 0.68-0.91 0.001 0,93 0.79-1.09 0.345
Prenatal service
Public 13.413 79.3 1 <0.001 1
Private 3.462 91.2 2.49 2.02-3.07 1.47 1.17-1.86 0.001
Start of prenatal care
>28th week 747 59.3 1 1
13th to 28th weeks 7.079 77.6 2.43 1.91-3.09 <0.001 1.88 1.39-2.54 <0.001
Up to 12th week 9.020 87.0 4.68 3.66-5.99 2.34 1.70-3.21
Adequate number of consultations6
No 4.756 66.7 1 <0.001 1
Yes 12.141 87.5 3.45 2.99-3.99 2.17 1.87-2.52 <0.001
1Only women who attended antenatal care; 2All the analyses were adjusted for the following variables: region of residence, age, schooling level, skin color,
conjugal situation, type of prenatal service, time when prenatal care started and adequacy of number of consultations for the gestational age; 3OR = odds ratio;
4CI = confidence interval; 5Pregnant women with East Asian or indigenous skin color were excluded from this analysis; 6Minimum of six consultations for a term
pregnancy, adjusted for the gestational age at birth. Totals for these variables vary because of missing values.
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2.95; 95% CI 1.78-4.91). After adjustment for the other
variables, the strength of association with the woman’s
age increased, such that HIV infection among women
aged 20 years or over was four to six times greater than
that of adolescents. HIV infection was also associated
with syphilis coinfection (OR = 4.75; 95% CI 2.01-
11.21), with self-reported black skin color (OR = 2.89;
95% CI 1.57-5.31), with living without a partner (OR =1.87; 95% CI 1.21-2.87), with less than 8 years of school-
ing (OR = 2.26; 95% CI 1.28-3.98) and with delivery care
provided in public clinics (OR = 4.08; 95% CI 1.65-
10.08). If the births that took place in the public and
mixed clinics are analyzed together, the estimated
prevalence was 0.45% (95% CI: 0.36-0.58%), a rate that
was significantly higher than that observed in the pri-
vate clinics (0.10%; 95% CI: 0.04-0.22), with an OR of
4.67 (95% CI: 2.02-10.80).
Table 4 Univariate and multivariable logistic regression on the maternal characteristics associated with HIV infection,
Brazil, 2011-2012
Maternal characteristics Prevalence of HIV
infection (%)
95% CI Univariate analysis Multivariable analysis1
OR2 95% CI3 p OR2 95% CI3 p
Region of residence
Southeast 0.34 0.24-0.50 1 1
North 0.44 0.18-1.09 1.30 0.49-3.47 1.11 0.43-2.90
Northeast 0.29 0.15-0.57 0.82 0.38-1.75 0.70 0.31-1.58
South 0.87 0.64-1.18 2.51 1.55-4.09 0.001 2.95 1.78-4.91 <0.001
Midwest 0.31 0.13-0.77 0.91 0.34-2.43 0.92 0.34-2.46
Maternal age
12 to 19 years 0.14 0.07-0.28 1 1
20 to 34 years 0.44 0.34-0.58 3.04 1.47-6.30 0.004 4.45 2.08-9.51 <0.001
35 and over 0.60 0.35-1.04 4.17 1.75-9.98 6.33 2.54-15.80
Schooling level (years)
11 or more 0.24 0.16-0.35 1 1
8 to 10 0.48 0.27-0.86 2.12 1.03-4.33 2.03 0.97-4.26
0 to 7 0.63 0.46-0.87 2.78 1.62-4.78 0.001 2.26 1.28-3.98 0.014
Skin color4
White 0.32 0.23-0.46 1 1
Mixed 0.35 0.25-0.48 1.08 0.67-1.74 1.09 0.67-1.79
Black 1.09 0.65-1.82 3.38 1.78-6.39 <0.001 2.89 1.57-5.31 0.001
Conjugal situation
With partner 0.35 0.26-0.47 1 1
Without partner 0.63 0.44-0.90 1.83 1.18-2.86 0.008 1.87 1.21-2.87 0.005
Syphilis infection5
No 0.38 0.29-0.48 1 1
Yes 2.86 1.20-6.70 7.92 3.05-20.58 <0.001 4.75 2.01-11.21 <0.001
Type of delivery service6
Private 0.10 0.04-0.22 1 1
Mixed 0.33 0.22-0.50 3.40 1.38-8.38 2.11 0.83-5.34
Public 0.58 0.43-0.79 5.94 2.53-13.96 <0.001 4.08 1.65-10.08 0.003
1All the analyses were adjusted for the following variables: region of residence, age, schooling level, skin color, conjugal situation, syphilis infection and type of
delivery care service (public, mixed or private).
2OR = odds ratio; 3CI = confidence interval; 4Pregnant women with East Asian or indigenous skin color were excluded from this analysis.
5Women who presented with one of the following criteria were considered to present syphilis infection: record of a reactive serological test for syphilis on the
prenatal card or the hospital medical files; record of a diagnosis of syphilis on the prenatal card or the hospital medical files; or a case of congenital syphilis as an
outcome from the present pregnancy.
6Type of delivery service: public = deliveries only with public funding; private = deliveries only with private funding; mixed = deliveries with either public or private funding.
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The results of this study demonstrate that coverage of
prenatal care with at least one consultation is practically
universal in Brazil, reaching levels greater than 90%, ir-
respective of the geographical region of the country or
maternal characteristics. Nonetheless, a slightly lower
coverage was observed in the North region and among
women with less schooling, indigenous women, and
women without a partner, probably as a result of geo-
graphical access, and cultural and social barriers.Provision of a prenatal card was a well-established prac-
tice, without regional differences, and this result was
similar to that observed in a recent national study [32].
More than 80% of the women who presented with
their prenatal card at the time of hospital admission for
delivery had prenatal cards with the results from the first
HIV serological test. This proportion was higher than
that observed in the Sentinel Parturient Study of 2006
[4], when 62.8% of the pregnant women analyzed pre-
sented with an HIV serological test. Our results thus
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[13,18,19,23,24], which indicated coverage close to 80%.
Although a notable increase in this coverage was seen,
regional differences were still observed. The South re-
gion was the only one to attain coverage greater than
90%, which is the target defined by World Health
Organization (WHO) for vertical HIV transmission con-
trol programs [33], but this is still lower than the cover-
age of 95% proposed by PAHO for the Latin American
and Caribbean region [22].
Younger women, with less schooling and who self-
reported as black or mixed, who were living in the North
and Northeast regions, and whose prenatal care was pro-
vided in public clinics, with a late start and an insufficient
number of consultations, were the ones who presented
with the lowest coverage of at least one HIV test during
pregnancy. These results show the importance of an early
start to prenatal care and an adequate number of consulta-
tions for undertaking routine examinations, as already
demonstrated in other studies [23,34,35], thus enabling
timely implementation of care protocols for preventing
vertical transmission. The results also reveal inequalities
in control measures that may not reach women with
greater social vulnerability, i.e., younger women with less
schooling and black and mixed skin color, who live in less
developed regions of the country. It is important to note
that this state of inequality has remained unchanged over
the years, given that these results have already been ob-
served in national studies conducted at the beginning of
the 2000s [4,34-36]. Similar inequalities have been de-
scribed in Africa [37].
The rate of performing a second test is still poor in the
country: less than 30%, with marked regional differences.
Although differences in coverage by characteristics of
women have been observed, the coverage attained has been
low, even among those in a better socioeconomic condition
who were attended in private clinics. The Brazilian Ministry
of Health introduced the second serological test for HIV in
2006 [38], as part of the prenatal care routine. The low
coverage observed reveals that there have been problems in
implementing this recommendation.
Brazilian Guidelines recommend that all pregnant
women without any previous serological test or without
serological results from the third trimester of pregnancy
have a rapid HIV test performed at admission for delivery.
The observed low coverage of the second serological test,
both in public and in private clinics, gives rise to the need
to perform testing on a greater number of women at the
time of admission for delivery, thus overloading these ser-
vices and making it difficult to diagnose the infection, hin-
dering timely implementation of preventive measures
against vertical transmission. Moreover, other aspects of
care are also impacted, such as delaying the start of breast-
feeding after delivery [39].The prevalence of HIV infection among the pregnant
women of this study (0.40%) was similar to that ob-
served in the Sentinel Parturient Studies conducted in
2004 (0.41%) [40], 2006 (0.41%) [4], and 2010 (0.38%)
[3]. However, because private clinics were not included
in these Sentinel Studies, comparisons between these
and our data are difficult. When the births that took
place only in the public and mixed clinics of our study
are analyzed separately (i.e. using the criteria of the
Sentinel Studies), the estimated prevalence was signifi-
cantly higher than that observed in the private clinics.
This is a novel result for Brazil, and it demonstrates that
there is a greater prevalence of infection among female
users of clinics within the Brazilian National Health
System (SUS), which is a population formed by women
of poor socioeconomic condition.
The South region had the highest prevalence of HIV
infection among pregnant women in this country, and
the North region had the second highest prevalence, al-
though with no significant difference in comparison to
the Southeast region. Data from local studies have also
shown a higher prevalence in the North (0.6%) [41] and
South regions (1.7%) [42]. Studies conducted in the
Southeast [24], Northeast [43] and Midwest [44,45] re-
gions have found prevalence values not statistically differ-
ent from those estimated in our study for these regions.
The results indicated a higher prevalence of HIV infec-
tion with increasing age. The decline in mortality due to
AIDS in Brazil since the 2000s [3], with increasing sur-
vival among HIV-infected individuals [46,47], is one pos-
sible explanation. The high proportion of pregnant
women with diagnoses of HIV infection prior to the
current pregnancy, which has been reported in several
national studies [11,13,14,18,19], suggests that women
who have been infected for longer periods are becoming
pregnant, which may also explain the increase in preva-
lence with age.
A higher prevalence was also observed among women
with less schooling, who were single, who self-reported as
black and had diagnoses of syphilis infection. Syphilis in-
fection is a known risk factor for HIV infection [30,31],
and a combined approach to these two diseases is recom-
mended by WHO for better results in programs for pre-
venting vertical transmission of both diseases [48].
The greater prevalence of cases among women with less
than 8 years of schooling, who were single, who self-
reported as black and as users of public clinics may reflect
greater social vulnerability in these groups. However, the
absence of other variables relating to the women’s behav-
ior, such as sexual partnerships, drug use and access to
condoms, makes it more complex to interpret the associa-
tions encountered. A study conducted in 13 Brazilian cit-
ies [49] found that there was greater use of drugs, an
earlier start to sexual life, low adherence to condom use
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violence among the women living with HIV/AIDS. It
should be emphasized that black women, those with less
schooling and those attended in public clinics, who had
high odds ratios for HIV infection, were the women who
presented with the lowest coverage of testing. This reveals
missed opportunities for making diagnoses in the popula-
tion most affected by the infection.
This study was conducted in institutions where more
than 500 deliveries take place every year. It is likely that
pregnant women who deliver at home or in smaller hospi-
tals have different degrees of access to prenatal services and
routine examinations. Nonetheless, given that more than
99% of deliveries in Brazil take place in hospitals, and ap-
proximately 80% in larger hospitals [25], significant changes
to the results presented here would not be expected.
One limitation of the present study was that the re-
sults from the HIV tests were only ascertained among
the women who presented with the prenatal card at the
time of hospital admission for delivery (71.6%). However,
the estimates presented here for the coverage of HIV
testing during pregnancy are not thought to be overesti-
mated, because the women who least often presented
with a prenatal card were the ones with the most school-
ing and who were attended in private clinics, which also
had higher test coverage. This less frequent presentation
of the card probably resulted from the care model in the
private sector, in which the same professional provides
the prenatal and delivery care. Thus, it is unlikely that
these women who did not present a card had done anti-
HIV tests less often during pregnancy.
Another limitation of the present study was that the
serological tests were not performed in a standardized
manner, with use of secondary data to estimate the preva-
lence of HIV infection. It is possible that failures in record-
ing the medical file data may have led to underestimation
of this infection in the cases of women who did not present
a prenatal card on admission for delivery.
Finally, our eligibility criteria excluded women with
miscarriages. This exclusion may have introduced bias in
the estimated prevalence of HIV infection in pregnancy
if women with miscarriages tend to have an increased
likelihood of HIV infection [50,51].
Conclusions
The present study found a 0.40% prevalence of HIV in-
fection among pregnant women, an almost universal
coverage of antenatal care, and coverage of prenatal HIV
testing of over 80%. Nevertheless, regional and social in-
equalities in accessing healthcare services, the low im-
plementation of the second anti-HIV serological test,
and the lower coverage of testing among women with
characteristics associated with greater prevalence of HIV
infection indicate shortcomings in the HIV infectioncontrol programs during pregnancy. These missed oppor-
tunities probably contributed to the high vertical transmis-
sion of HIV infection in specific group populations,
despite the available resources guaranteed by public pol-
icies since the 1990s. This result stresses the importance
of designing and implementing interventions targeted to
the people most affected by the epidemic that would most
benefit from the interventions available to prevent
mother-to-child transmission of HIV infection. The moni-
toring of the prevalence of HIV infection among pregnant
women to identify the groups most affected by the epi-
demic, as well as the monitoring and evaluation of ante-
natal care and HIV program indicators, are important
tools for the development of these specific interventions.
Endnotes section
aThe Brazilian national HIV testing system at the time
of the study [52] recommended the use of tests in two
stages: a screening stage and a confirmatory stage. Rapid
tests can be used in both stages if they have been vali-
dated by the National Department of STD/Aids and if
they are able to detect anti-HIV-1 antibodies, including
group O and HIV-2 antibodies
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